4.4 Article

Disease-associated mutations in mitochondrial precursor tRNAs affect binding, m1R9 methylation, and tRNA processing by mtRNase P

Journal

RNA
Volume 27, Issue 4, Pages 420-432

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1261/rna.077198.120

Keywords

RNase P; PRORP; pre-tRNA; tRNA processing; mitochondrial diseases; tRNA mutations

Funding

  1. National Institutes of Health [R01 GM117141, GM55387]
  2. Robert A. Welch Foundation [A-1987]
  3. American Heart Association predoctoral fellowship [16PRE29890011]

Ask authors/readers for more resources

Mitochondrial diseases are often caused by mutations in mitochondrial tRNA sequences. Research shows that mutations in tRNA can weaken the activity of mtRNase P, leading to mitochondrial dysfunction. Furthermore, mutations in pre-tRNAs can disrupt 5' end processing and methylation activity, contributing to the development of mitochondrial diseases.
Mitochondrial diseases linked to mutations in mitochondrial (mt) tRNA sequences are common. However, the contributions of these tRNA mutations to the development of diseases is mostly unknown. Mutations may affect interactions with (mt)tRNA maturation enzymes or protein synthesis machinery leading to mitochondrial dysfunction. In human mitochondria, in most cases the first step of tRNA processing is the removal of the 5' leader of precursor tRNAs ( pre-tRNA) catalyzed by the three-component enzyme, mtRNase P. Additionally, one component of mtRNase P, mitochondrial RNase P protein 1 (MRPP1), catalyzes methylation of the R9 base in pre-tRNAs. Despite the central role of 5' end processing in mitochondrial tRNA maturation, the link between mtRNase P and diseases is mostly unexplored. Here, we investigate how 11 different human disease-linked mutations in (mt)pre-tRNA(Ile), (mt)pre-tRNA(Leu(UUR)), and (mt)pre-tRNA(Met) affect the activities of mtRNase P. We find that several mutations weaken the pre-tRNA binding affinity (K(D)s are approximately two- to sixfold higher than that of wild-type), while the majority of mutations decrease 5' end processing and methylation activity catalyzed by mtRNase P (up to similar to 55% and 90% reduction, respectively). Furthermore, all of the investigated mutations in (mt)pre-tRNA(Leu(UUR)) alter the tRNA fold which contributes to the partial loss of function of mtRNase P. Overall, these results reveal an etiological link between early steps of (mt)tRNA-substrate processing and mitochondrial disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available